Latest Data & Signals Issued

Below are some of the latest signals issued for MacroGenics

General

Signal Type Signal Value Data
Score 0.000 29 days ( -33.24 %
Last Price $4.69 2.40 %
Performance History
7 Days
$3.88 $4.69
20.88%
30 Days
$4.53 $4.69
3.53%
12 Mos
$1.32 $4.69
255.30%

17/18

Active Buy Signals

Specific Signals

Short Term
Net score: 100
Signal Type Signal Value Importance Data
High / Low Buy Very Low $4.56 - $4.94
Position: 35.06% from low / 64.94% from high · Momentum: 27.46%
Trend - 3 mos 42.83 % High Width: 25.29 %
Pred. range - 3 mos $5.41 - $6.78 Low 15.42 % - 44.61 %
Volume Direction Buy High Volume: 1,263,953 · Direction: 1.00
Pivot Short Buy Very Low Apr 29, 2026 - 38 days
RSI Short Pivot Signal Buy Very Low Jun 16, 2026 - 5 days
Short MA 3 mos Buy Low Jun 17, 2026 - 4 days
Long MA 3 mos Buy Medium May 11, 2026 - 30 days
Short/Long MA 3 mos Buy Medium May 13, 2026 - 28 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 88.19
Signal Type Signal Value Importance Data
Trend - 12 mos 163.26 % Very High Width: 54.33 %
Pred. range - 12 mos $7.19 - $11.10 High 53.29 % - 136.58 %
Short MA 12 mos Buy Very High Jun 18, 2026 - 3 days
Long MA 12 mos Buy Very High Dec 30, 2025 - 120 days
Short/Long MA 12 mos Buy Very High Jan 13, 2026 - 111 days
Pivot Long Buy Low Mar 24, 2026 - 63 days
RSI Long Pivot Signal Buy Low Jun 18, 2026 - 3 days
Bollinger Buy Medium Jun 22, 2026 - 2 days
MACD Sell High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT MACROGENICS
MacroGenics
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE